NEGLIGIBLE METABOLIC EFFECTS OF LONG-TERM ORAL TREATMENT WITH A NEW BETA-2-AGONIST - BROXATEROL

被引：0
|
作者：
PETRAGLIA, A [1 ]
SCARPITTA, M [1 ]
ANSALONE, D [1 ]
GURRIERI, G [1 ]
GALZERANO, V [1 ]
CALVANESE, RC [1 ]
FEDERICO, S [1 ]
ZINNO, A [1 ]
机构：
[1] ZAMBRON GRP,CORP MED AFFAIRS,MILAN,ITALY
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH | 1990年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：299 / 304
页数：6
相关论文
共 50 条
  • [41] A COMPARISON OF THE EFFECTS OF ANTICHOLINERGIC AND BETA-2-AGONIST AND COMBINATION THERAPY ON RESPIRATORY IMPEDANCE IN COPD
    WESSELING, G
    MOSTERT, R
    WOUTERS, EFM
    CHEST, 1992, 101 (01) : 166 - 173
  • [42] ANTIHYPERTENSIVE EFFICACY AND METABOLIC EFFECTS OF LONG-TERM TREATMENT WITH FENQUIZONE
    CALDARI, R
    COSTA, FV
    BORGHI, C
    MONTEBUGNOLI, L
    GIORDANI, FM
    AMBROSIONI, E
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1982, 2 (04) : 289 - 293
  • [43] ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF LONG-TERM TREATMENT WITH NIFEDIPINE (ADALAT)
    GUINTOLI, F
    ROSSI, A
    SCALABRINO, A
    NATALI, A
    SABA, P
    PAGLIAI, E
    GALEONE, F
    CLINICAL TRIALS JOURNAL, 1985, 22 (03) : 231 - 238
  • [44] Long-term and late treatment consequences: endocrine and metabolic effects
    Han, Thang S.
    Gleeson, Helena K.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2017, 11 (03) : 205 - 213
  • [45] LATE ASTHMATIC REACTION DECREASED AFTER PRETREATMENT WITH SALBUTAMOL AND FORMOTEROL, A NEW LONG-ACTING BETA-2-AGONIST
    PALMQVIST, M
    BALDER, B
    LOWHAGEN, O
    MELANDER, B
    SVEDMYR, N
    WAHLANDER, L
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (04) : 844 - 849
  • [46] A NEW LONG-ACTING BETA-2-AGONIST, FORMOTEROL IN COMPARISON WITH FENOTEROL AND SALBUTAMOL IN CHILDHOOD BRONCHIAL-ASTHMA
    VONBERG, A
    BERDEL, D
    MONATSSCHRIFT KINDERHEILKUNDE, 1993, 141 (01) : 53 - 58
  • [47] ANTIATHEROSCLEROTIC EFFECTS OF LONG-TERM TREATMENT WITH ORAL DILTIAZEM HYDROCHLORIDE
    ISHIGURO, M
    IKEBA, K
    NAKANO, S
    OHASHI, H
    WATANABE, S
    YASUE, T
    KISHIMOTO, T
    JOU, Y
    SEKI, I
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1991, 50 (05): : 678 - 690
  • [48] EFFECTS ON BONE METABOLISM OF LONG-TERM ORAL ANTICOAGULANT TREATMENT
    VANDERLINDEN, T
    HOUVENAGEL, E
    GRAUX, P
    LELOIRE, O
    FORZY, G
    CABARET, P
    TISON, F
    MARCHANDISE, X
    DUTOIT, A
    VINCENT, G
    CROCCEL, L
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1991, 40 (07): : 405 - 407
  • [49] LONG-TERM METABOLIC EFFECTS OF GLIBENCLAMIDE AND GLIPIZIDE IN THE TREATMENT OF TYPE-2 DIABETES
    GROOP, PH
    STENMAN, S
    TOTTERMAN, KJ
    BACKS, C
    MELANDER, A
    WAHLINBOLL, E
    GROOP, L
    ACTA ENDOCRINOLOGICA, 1985, 110 : U37 - U37
  • [50] Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist
    Salvator, Helene
    Buenestado, Amparo
    Brollo, Marion
    Naline, Emmanuel
    Victoni, Tatiana
    Longchamp, Elisabeth
    Tenor, Hermann
    Grassin-Delyle, Stanislas
    Devillier, Philippe
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345